Over the past several years, procedural volumes, particularly with total joints, have been migrating from the hospital outpatient department to ambulatory surgery centers (ASCs) at an accelerated pace. With the potential to provide over $55 billion per year in healthcare cost savings in the U.S., this rapid shift in site of care is expected to continue over the next few years in the post-pandemic environment.
To meet the unique needs of this emerging customer, Stryker launched an ASC-focused business earlier this year.
“By offering ASCs access to the breadth and depth of Stryker’s portfolio, teams who understand the ASC landscape, and ongoing support to help build and grow their business, we are committed to delivering tailored solutions for ASCs to achieve their mission and goals,” said Andy Pierce, Stryker’s group president of MedSurg and Neurotechnology.
With thousands of unique products spanning more than 20 procedural specialties, and a wide range of flexible financial options, Stryker is ready to meet the complex needs of ASCs while continuing to add value to healthcare.
Learn more about Stryker’s ASC-focused business here.